Literature DB >> 3113703

Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women.

A G Need, H A Morris, T F Hartley, M Horowitz, B E Nordin.   

Abstract

Although anabolic steroids have been used for many years to treat osteoporosis there is little available evidence about their efficacy or mode of action. These agents have recently been shown to produce an increase in total body calcium and bone density and it has been suggested that they stimulate bone formation. In this study 27 osteoporotic postmenopausal women were given 50 mg of nandrolone decanoate intramuscularly, every 2 or 3 weeks for 3 months, and the changes in forearm mineral density, fasting plasma, and urinary calcium, urinary hydroxyproline, and radiocalcium absorption were measured. Associated with a rise in forearm mineral density was a significant fall in fasting urinary calcium, but no significant change in fasting urinary hydroxyproline. The plasma calcium and phosphate fell significantly and there was a significant rise in the renal tubular reabsorption of calcium and a fall in the renal tubular reabsorption of phosphate. In a subset of 22 patients there was a significant rise in radiocalcium absorption. The results are consistent with the concept that nandrolone exerts a significant positive effect on bone formation and that this results in a fall in the fasting plasma calcium level, and consequently calcium excretion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3113703     DOI: 10.1007/bf02555124

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  19 in total

1.  Anabolic steroids and osteoporosis.

Authors:  J Dequeker; P Geusens
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1985

2.  The estimation of the cross-sectional area of the ulna and radius.

Authors:  A Horsman; A E Leach
Journal:  Am J Phys Anthropol       Date:  1974-03       Impact factor: 2.868

3.  Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy.

Authors:  C Christiansen; M S Christensen; I Transbøl
Journal:  Lancet       Date:  1981-02-28       Impact factor: 79.321

4.  Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass.

Authors:  C H Chesnut; W B Nelp; D J Baylink; J D Denney
Journal:  Metabolism       Date:  1977-03       Impact factor: 8.694

5.  Long-term calcitonin therapy in postmenopausal osteoporosis.

Authors:  H E Gruber; J L Ivey; D J Baylink; M Matthews; W B Nelp; K Sisom; C H Chesnut
Journal:  Metabolism       Date:  1984-04       Impact factor: 8.694

6.  Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male.

Authors:  D T Baran; M A Bergfeld; S L Teitelbaum; L V Avioli
Journal:  Calcif Tissue Res       Date:  1978-12-08

7.  A comparison of radioactive calcium absorption tests with net calcium absorption.

Authors:  D H Marshall; B E Nordin
Journal:  Clin Sci (Lond)       Date:  1981-10       Impact factor: 6.124

8.  Treatment of spinal osteoporosis in postmenopausal women.

Authors:  B E Nordin; A Horsman; R G Crilly; D H Marshall; M Simpson
Journal:  Br Med J       Date:  1980-02-16

9.  1,25-Dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Dose response relationship of calcium absorption and indices of bone turnover.

Authors:  A G Need; M Horowitz; J C Philcox; B E Nordin
Journal:  Miner Electrolyte Metab       Date:  1985

10.  Calcium metabolism evaluated by 47calcium-kinetics: a physiological model with correction for faecal lag time and estimation of dermal calcium loss.

Authors:  F T Jensen; P Charles; L Mosekilde; H H Hansen
Journal:  Clin Physiol       Date:  1983-04
View more
  3 in total

1.  Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis.

Authors:  L Flicker; J L Hopper; R G Larkins; M Lichtenstein; G Buirski; J D Wark
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  [Prophylaxis and treatment of osteoporosis].

Authors:  H Kopera
Journal:  Klin Wochenschr       Date:  1989-05-15

Review 3.  Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis.

Authors:  P Geusens
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.